The candidate will provide leadership, subject matter expertise, and coordination for NCI’s Moonshot activities related to adult and pediatric cancer genomics and the utilization of shared resources to ensure achievement of Cancer Moonshot Initiative and Blue-Ribbon Panel goals. In doing so, the candidate will be expected to design and initiate programs, build infrastructure, build teams, and execute new scientific initiatives. The candidate will be expected to provide expert knowledge and first-hand experience in developing and improving genomic data systems and technologies into which sequencing data and high-content functional screening data will be deposited to facilitate breakthrough findings for improved treatments. The candidate will manage a portfolio of contracts and grants supporting cancer genomics and translational research totaling nearly $30 million that support the achievement of the Cancer Moonshot Initiative and Blue Ribbon Panel goals and forward NCI’s priorities in cancer genomics.
Applicants must possess a doctoral level degree (e.g. Ph.D. or M.D.) in
an academic filed related to the health sciences or allied sciences appropriate to the work of this
experience and equivalent experience. We are seeking a senior level candidate with practical experience with highly specialized science, data, and management scenarios and concepts to provide the required authoritative guidance, management leadership, and unique expertise to build and sustain a diverse, highly complex, and highly visible cancer genomics research program that meets the objectives of the Cancer Moonshot and Blue-Ribbon Panel recommendations. Also, this position serves as a supervisor and should have supervisory experience in managing high-level scientists and administrative staff.
The National Cancer Institute (NCI) is seeking an innovative leader to serve as the Associate Director of Precision Oncology Research within the Center for Cancer Genomics (CCG) (www.cancer.gov/about-nci/organization/ccg). The CCG oversees NCI-wide genomics-based initiatives to accelerate the creation and use of tools that will bring a new understanding about the molecular underpinnings of different forms of cancer in children and adults